Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia
Clinical trial NCT00914628 · TERMINATED
Trial details
- NCT number
- NCT00914628
- Sponsor
- AGC Biologics S.p.A.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-12
- Primary completion
- 2019-11-30
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.